REG - Hikma Pharmaceutical - Holding(s) in Company
RNS Number : 6889EHikma Pharmaceuticals Plc09 November 2020
TR-1: Standard form for notification of major holdings
LONDON, 9 November 2020 - Hikma Pharmaceuticals PLC (LEI:549300BNS685UXH4JI75) (LSE: HIK) (NasdaqDubai: HIK) (LSE: HIK) announces as follows:
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:
Hikma Pharmaceuticals PLC
1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights
X
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Details of person subject to the notification obligation
Name
Wellington Management Group LLP
City and country of registered office (if applicable)
Boston, USA
4. Full name of shareholder(s) (if different from 3)
Name
Bank of New York (Nominees) Ltd
BBH ISL NOMINEES LTD
BNY (OCS) Nominees Limited
GOLDMAN SACHS INTERNATIONAL
HSBC Global Custody Nominee (UK) Limited
Japan Trustee Services Bank Ltd.
JP Morgan Chase Nominees Limited
Mellon Nominees (UK) Ltd.
Nortrust Nominees Limited
ROY Nominees Limited
State Street Nominees Limited
VIDACOS NOMINEES LIMITED
City and country of registered office (if applicable)
5. Date on which the threshold was crossed or reached:
05/11/2020
6. Date on which issuer notified (DD/MM/YYYY):
06/11/2020
7. Total positions of person(s) subject to the notification obligation:
% of voting rights attached to shares
(total of 8.A)
% of voting rights through financial instruments
(total of 8.B.1 + 8.B.2)
Total of both in %
(8.A + 8.B)
Total number of voting rights of issuer
Resulting situation on the date on which threshold was crossed or reached
5.00%
0.01%
5.01%
230,496,614
Position of previous notification (if applicable)
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached:
A: Voting rights attached to shares
Class/type of shares ISIN code (if possible)
Number of voting rights
% of voting rights
Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)
Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)
Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)
Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)
GB00B0LCW083 Common Stock
11,522,905
5.00%
SUBTOTAL 8.A
11,522,905
5.00%
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
Type of financial instrument
Expiration date
Exercise/ Conversion Period
Number of voting rights that may be acquired if the instrument is exercised/converted
% of voting rights
SUBTOTAL 8.B.1
B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of financial instrument
Expiration date
Exercise/ Conversion Period
Physical or cash settlement
Number of voting rights
% of voting rights
Equity Swap
22/05/2023
08/10/2018to22/05/2023
Cash settlement
6,615 Equity Swap shares or 6,615 votes on a converted basis
0.00%
Equity Swap
15/05/2023
02/03/2018to15/05/2023
Cash settlement
4,378 Equity Swap shares or 4,378 votes on a converted basis
0.00%
Equity Swap
15/05/2023
10/10/2017to15/05/2023
Cash settlement
4,019 Equity Swap shares or 4,019 votes on a converted basis
0.00%
Equity Swap
22/05/2023
05/10/2018to22/05/2023
Cash settlement
1,931 Equity Swap shares or 1,931 votes on a converted basis
0.00%
Equity Swap
15/05/2023
16/07/2018to15/05/2023
Cash settlement
1,455 Equity Swap shares or 1,455 votes on a converted basis
0.00%
Equity Swap
15/05/2023
02/02/2018to15/05/2023
Cash settlement
1,450 Equity Swap shares or 1,450 votes on a converted basis
0.00%
Equity Swap
22/05/2023
08/01/2019to22/05/2023
Cash settlement
1,434 Equity Swap shares or 1,434 votes on a converted basis
0.00%
Equity Swap
15/05/2023
02/07/2018to15/05/2023
Cash settlement
1,376 Equity Swap shares or 1,376 votes on a converted basis
0.00%
Equity Swap
22/05/2023
03/07/2018to22/05/2023
Cash settlement
1,317 Equity Swap shares or 1,317 votes on a converted basis
0.00%
Equity Swap
15/05/2023
23/10/2017to15/05/2023
Cash settlement
1,156 Equity Swap shares or 1,156 votes on a converted basis
0.00%
Equity Swap
15/05/2023
11/06/2018to15/05/2023
Cash settlement
1,138 Equity Swap shares or 1,138 votes on a converted basis
0.00%
Equity Swap
22/05/2023
15/07/2019to22/05/2023
Cash settlement
1,134 Equity Swap shares or 1,134 votes on a converted basis
0.00%
Equity Swap
22/05/2023
05/04/2018to22/05/2023
Cash settlement
1,124 Equity Swap shares or 1,124 votes on a converted basis
0.00%
Equity Swap
05/05/2023
10/09/2020to05/05/2023
Cash settlement
956 Equity Swap shares or 956 votes on a converted basis
0.00%
Equity Swap
05/05/2023
11/09/2020to05/05/2023
Cash settlement
871 Equity Swap shares or 871 votes on a converted basis
0.00%
Index Future
05/11/2020
01/01/1900to05/11/2020
Cash settlement
1,289 Index Future shares or 840 votes on a converted basis
0.00%
Equity Swap
15/05/2023
27/07/2018to15/05/2023
Cash settlement
709 Equity Swap shares or 709 votes on a converted basis
0.00%
Equity Swap
15/05/2023
26/03/2018to15/05/2023
Cash settlement
517 Equity Swap shares or 517 votes on a converted basis
0.00%
Equity Swap
15/05/2023
16/04/2018to15/05/2023
Cash settlement
445 Equity Swap shares or 445 votes on a converted basis
0.00%
Equity Swap
05/05/2023
30/07/2018to05/05/2023
Cash settlement
291 Equity Swap shares or 291 votes on a converted basis
0.00%
Equity Swap
05/05/2023
24/09/2020to05/05/2023
Cash settlement
249 Equity Swap shares or 249 votes on a converted basis
0.00%
Equity Swap
05/05/2023
24/09/2020to05/05/2023
Cash settlement
197 Equity Swap shares or 197 votes on a converted basis
0.00%
Equity Swap
05/05/2023
09/09/2020to05/05/2023
Cash settlement
193 Equity Swap shares or 193 votes on a converted basis
0.00%
Equity Swap
15/05/2023
18/06/2018to15/05/2023
Cash settlement
177 Equity Swap shares or 177 votes on a converted basis
0.00%
Equity Swap
05/05/2023
24/09/2020to05/05/2023
Cash settlement
5 Equity Swap shares or 5 votes on a converted basis
0.00%
SUBTOTAL 8.B.2
33,977
0.01%
9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.
Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary)
X
Name
% of voting rights if it equals or is higher than the notifiable threshold
% of voting rights through financial instruments if it equals or is higher than the notifiable threshold
Total of both if it equals or is higher than the notifiable threshold
Wellington Management Group LLP
5.01%
Wellington Group Holdings LLP
5.01%
Wellington Investment Advisors Holdings LLP
5.01%
Wellington Management Company LLP
Wellington Management Group LLP
5.01%
Wellington Group Holdings LLP
5.01%
Wellington Investment Advisors Holdings LLP
5.01%
Wellington Management Global Holdings, Ltd.
Wellington Management International Ltd
10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional information:
Place of completion
Boston, MA USA
Date of completion
06/11/2020
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDHOLUKOARRVUARAA
Recent news on Hikma Pharmaceuticals
See all newsREG - Hikma Pharmaceutical - Result of AGM
AnnouncementREG - Hikma Pharmaceutical - Trading Statement
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
AnnouncementREG - Hikma Pharmaceutical - Hikma appoints new President of Generics business
AnnouncementREG - Hikma Pharmaceutical - Director/PDMR Shareholding
Announcement